FAQ
We have collected a list of frequently asked questions about buying, selling and licensing medical patents for your convenience. However, if you have more complex or individualized questions, please contact us directly. We welcome the opportunity to discuss it with you.
Our mission:
To assist in improving healthcare by providing an effective platform for the commercialization of extraordinary inventions beneficial to the human race.
Frequently Asked Questions
Basic Information
A medical patent is a legal asset granted by a specialized federal authority—such as the United States Patent and Trademark Office (USPTO)—that discloses a novel invention. Because of its medical nature, the underlying invention typically requires subsequent governmental clearance or regulatory approval before it can be legally sold or used in commerce. Examples of these downstream regulatory and market approval agencies include the US Food and Drug Administration (FDA), the US Centers for Medicare & Medicaid Services (CMS), and the Centers for Disease Control and Prevention (CDC).
The Medical Patents Broker Inc. ("MPB") marketplace is a specialized platform where companies, corporations, hospitals, individuals, non-profit organizations, universities, and venture capitalists can commence, negotiate, and facilitate a “meeting of the minds” for buying, selling, or licensing medical patents. MPB’s marketplace also hosts the Directory of Experts and the NEED Expert ASAP Dispatch Alert feed, where industry professionals can advertise services or respond to urgent requests.
“If they don't know about it, they won't buy it!” this quote is attributed to Philip Kotler (Kellogg School of Management at Northwestern University).
Medical Patents Broker Inc. provides a marketplace for the medical inventions described in medical patents.
There is no charge to list a medical patent.
When MPB facilitates an initial offer from a buyer/licensee to a seller/licensor, the transactional commission rates payable solely by the seller/licensor are structured as follows:
- 12% for a Straight Sale (Full Assignment).
- 18% for a Hybrid Transaction (Part Sale, Part License).
- 24% for a Straight License (Ownership Retained).
- Add 3% to each of the above for a private listing Patent Maestro® Vault.
The Directory is a public advertising venue viewable by all users of MPB’s marketplace. Listings are strictly limited to individuals and entities with verified expertise in moving medical inventions and their foundational patents through regulatory channels (such as the FDA, CMS, CDC, and USPTO) as well as entities (escrow, financial, insurance, legal, quality management, healthcare economics, technical document support, investment networks) that support those moving the invention to the market and the patient. Annual advertising subscription fees range from $330.00 to $4,500.00 depending on placement tier.
When a party moving a medical invention through regulatory channels encounters an unprecedented, time-critical problem, they can utilize the Dispatch system to source immediate help. For a flat $330.00 fee, MPB will publicly broadcast the urgent ASAP Dispatch Alert across its digital ecosystem for at least twenty-one (21) days.
No. To preserve platform integrity and legal compliance, all marketplace activities (including buyer/licensee offers, seller/licensor listings, Directory applications, and ASAP Dispatches) must be initiated through the standardized pathways identified on MPB’s Home Page. Whether an individual or an international, no exceptions will be granted.
No. Cash values or receivables remain confidential.
Buyer & Seller Questions
No. Medical Patents Broker Inc. will only list a medical patent when one of its evaluators concludes the evaluated medical patent discloses more than what Medical Patents Broker Inc. considers small differences relative to the comparative prior art patents and US public patent applications.
Yes.
No.
No, Medical Patents Broker, Inc. does not assist with securing governmental regulatory approval for an invention disclosed in a medical patent.
Yes. An invention disclosed in a patent that has regulatory approval for use in commerce will be listed on Medical Patents Broker, Inc's platform at a higher price than an invention not having regulatory approval.